JPMorgan Chase & Co. upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from an underweight rating to a neutral rating in a research report report published on Friday, Marketbeat Ratings reports. They currently have $14.00 price objective on the stock. TEVA has been the subject of a number of other reports. HSBC began […]
JPMorgan Chase & Co. upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from an underweight rating to a neutral rating in a research note published on Friday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has $14.00 target price on the stock. Several other brokerages also recently weighed in on TEVA. The Goldman […]
Critical Review: Athersys (NASDAQ:ATHX) versus Teva Pharmaceutical Industries (NYSE:TEVA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tudor Investment Corp Et Al Buys 208,776 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Tudor Investment Corp Et Al Has $9.12 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.